Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM
A recap of the Certainty 2026 Discovery UGM in Boston, covering the top themes from…
Certara2026年6月15日
2026 Simcyp Workshops
Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…
Certara2026年6月11日
QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials
QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…
Certara2026年6月11日
Model Smarter, Not Harder: Introducing Model Designer
2026年6月30日, 10:00 – 11:00 AM ET | 2026年7月2日, 10:00 – 11:00…
Danielle Pillsbury2026年6月10日
Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies
Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.
Certara2026年6月9日
The Case for Simulating Pregnancy
Pregnant women are routinely excluded from drug trials, leaving clinicians without dosing guidance. Discover how…
Certara2026年6月9日
Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients
See how a QSP model guided efficacy-proximal FIH dosing for ISB 2001 in the TRIgnite-1…
Certara2026年6月4日
Applying AI-Driven Biosimulation to Drug Discovery
Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…
Certara2026年6月2日
